|
| It’s a numbers game—densitydependent MMP activity mediates cancer cell migration |
|
https://doi.org/10.18632/oncotarget.26115
Jude M. Phillip, Nahuel Zamponi, and Madonna P. Phillip
|
| 33867-33868 |
|
| A 17geneexpression profile to improve prognosis prediction in childhood acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.26116
Nicolas Duployez, Claude Preudhomme, and Meyling Cheok
|
| 33869-33870 |
|
| IRS2 deubiquitination by USP9X maintains anchorageindependent cell growth via Erk1/2 activation in prostate carcinoma cell line |
|
https://doi.org/10.18632/oncotarget.26049
Haruka Furuta, Hidehito Yoshihara, Toshiaki Fukushima, Yosuke Yoneyama, Akihiro Ito, Claire Worrall, Ada Girnita, Leonard Girnita, Minoru Yoshida, Tomoichiro Asano, Masayuki Komada, Naoyuki Kataoka, Kazuhiro Chida, Fumihiko Hakuno, and Shin-Ichiro Takahashi
|
| 33871-33883 |
|
| The core sequence of PIF competes for insulin/amyloid β in insulin degrading enzyme: potential treatment for Alzheimer’s disease |
|
https://doi.org/10.18632/oncotarget.26057
Soren Hayrabedyan, Krassimira Todorova, Marialuigia Spinelli, Eytan R. Barnea, and Martin Mueller
|
| 33884-33895 |
|
| Inhibition of storeoperated channels by carboxyamidotriazole sensitizes ovarian carcinoma cells to antiBclxL strategies through Mcl1 downregulation |
|
https://doi.org/10.18632/oncotarget.26084
Marie-Laure Bonnefond, Romane Florent, Sophie Lenoir, Bernard Lambert, Edwige Abeilard, Florence Giffard, Marie-Hélène Louis, Nicolas Elie, Mélanie Briand, Denis Vivien, Laurent Poulain, Pascal Gauduchon, and Monique N’Diaye
|
| 33896-33911 |
|
| Estrogen receptorbeta is a potential target for triple negative breast cancer treatment |
|
https://doi.org/10.18632/oncotarget.26089
David Austin, Nalo Hamilton, Yahya Elshimali, Richard Pietras, Yanyuan Wu, and Jaydutt Vadgama
|
| 33912-33930 |
|
| Isolation of cancer cells with augmented spheroidforming capability using a novel tool equipped with removable filter |
|
https://doi.org/10.18632/oncotarget.26092
Emi Fujibayashi, Norikazu Yabuta, Yukihiro Nishikawa, Toshihiro Uchihashi, Daisaku Miura, Kyoko Kurioka, Susumu Tanaka, Mikihiko Kogo, and Hiroshi Nojima
|
| 33931-33946 |
|
| Hepatitis B virus promotes βcateninsignalling and disassembly of adherens junctions in a Src kinase dependent fashion |
|
https://doi.org/10.18632/oncotarget.26103
Gesa von Olshausen, Maria Quasdorff, Romina Bester, Silke Arzberger, Chunkyu Ko, Maarten van de Klundert, Ke Zhang, Margarete Odenthal, Marc Ringelhan, Carien M. Niessen, and Ulrike Protzer
|
| 33947-33960 |
|
| Delayed adverse events in phase I trials of molecularly targeted and cytotoxic agents |
|
https://doi.org/10.18632/oncotarget.26104
Emma J. Jordan, James Spicer, and Debashis Sarker
|
| 33961-33971 |
|
| Inhibitory effects of pentoxifylline on inflammationrelated tumorigenesis in rat colon |
|
https://doi.org/10.18632/oncotarget.26119
Yohei Shirakami, Takahiro Kochi, Masaya Kubota, Hiroyasu Sakai, Takashi Ibuka, Kazuto Yoshimi, Takashi Kuramoto, Takuji Tanaka, Masahito Shimizu, and Mitsuru Seishima
|
| 33972-33981 |
|
| Sulforaphane inhibits growth and blocks Wnt/βcatenin signaling of colorectal cancer cells |
|
https://doi.org/10.18632/oncotarget.26125
Dominic B. Bernkopf, Gabriele Daum, Martina Brückner, and Jürgen Behrens
|
| 33982-33994 |
|
| Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of RICTOR/KRASaltered nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.26129
Dennis Ruder, Vassiliki Papadimitrakopoulou, Kazuhiko Shien, Carmen Behrens, Neda Kalhor, Huiqin Chen, Li Shen, J. Jack Lee, Waun Ki Hong, Ximing Tang, Luc Girard, John D. Minna, Lixia Diao, Jing Wang, Barbara Mino, Pamela Villalobos, Jaime Rodriguez-Canales, Nana E. Hanson, James Sun, Vincent Miller, Joel Greenbowe, Garrett Frampton, Roy S. Herbst, Veera Baladandayuthapani, Ignacio I. Wistuba, and Julie G. Izzo
|
| 33995-34008 |
|
| Lenalidomide combined with lowdose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes resulting in immunostimulatory effects in lenalidomiderefractory multiple myeloma patients |
|
https://doi.org/10.18632/oncotarget.26131
Laurens E. Franssen, Inger S. Nijhof, Chad C. Bjorklund, Hsiling Chiu, Ruud Doorn, Jeroen van Velzen, Maarten Emmelot, Berris van Kessel, Mark-David Levin, Gerard M.J. Bos, Annemiek Broijl, Saskia K. Klein, Harry R. Koene, Andries C. Bloem, Aart Beeker, Laura M. Faber, Ellen van der Spek, Reinier Raymakers, Pieter Sonneveld, Sonja Zweegman, Henk M. Lokhorst, Anjan Thakurta, Xiaozhong Qian, Tuna Mutis, and Niels W.C.J. van de Donk
|
| 34009-34021 |
|
| The role of different adjuvant therapies in locally advanced gastric adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.26106
Ilaria Benevento, Nadia Bulzonetti, Francesca De Felice, Daniela Musio, Massimo Vergine, and Vincenzo Tombolini
|
| 34022-34029 |
|
| Correction: p53 and metabolism: from mechanism to therapeutics |
|
https://doi.org/10.18632/oncotarget.26181
Fernando M. Simabuco, Mirian G. Morale, Isadora C.B. Pavan, Ana P. Morelli, Fernando R. Silva, and Rodrigo E. Tamura
|
| 34030-34030 |
